• Introducing the new mobilePDR®, the official drug information and comparison app from PDR®, now available from the Apple® App StoreSM and Google Play™

     – Get drug information fast — mobilePDR is the latest digital innovation from the Physicians’ Desk Reference®, offered at no cost to all US healthcare professionals –  

    Montvale, NJ – August 11, 2015PDR, LLC (PDR®), a leading provider of drug information, prescriber communications, and behavior-based patient and consumer health information, has released a completely reimagined mobilePDR®, the official drug information and comparison app for Apple® and Android™ devices. The app is a component of the Physicians' Desk Reference® suite of services, which provides healthcare professionals (HCPs) with multichannel access to important drug information. This suite includes distribution of interactive drug information services for EHR/EMR systems, digital communication services, PDR.net®, and mobilePDR, with timely updates to all drug information. For over 70 years, PDR has provided the most recognized and trusted drug information reference to HCPs throughout the United States.

    "PDR delivers innovative health information solutions to support prescribers, pharmacists, and other healthcare providers, in their preferred channel," said Mark Heinold, CEO of PDR. "The new mobilePDR provides actionable health information that matters, in the moment it is needed, to help providers make efficient, informed prescribing decisions for their patients."

    Among the many medical information apps available, mobilePDR stands apart as a fast-access, go-to mobile drug reference that gives HCPs confidence in their prescribing choices whenever, wherever those decisions are being made. Prescribing information is developed and updated continually by PDR’s team of PharmD clinicians, using the latest FDA-approved drug information to ensure that HCPs have accurate and informed drug information at their fingertips.

    mobilePDR was evaluated by healthcare providers throughout the development process, and is designed to help HCPs get direct, real-time access to:

    • Drug Summaries: access current drug summaries to answer questions quickly
    • Drug-to-Drug Comparisons: generate easy-to-create drug comparisons which allow for side-by-side viewing of specific drug features, such as dosing and contraindications
    • Drug-to-Drug Interactions: detect potentially harmful drug interactions early
    • Pill Identification: quickly identify unlabeled pills for patient safety
    "The new mobilePDR provides fast access to drug information on your phone or tablet, whether you’re on the clock, on call, or on vacation," said Salvatore Volpe, MD, Chief Medical Officer of PDR. "It’s fast, it’s easy to use, and, most importantly, the drug information is current."

    mobilePDR is now available at no cost for all US HCPs from the Apple App Store and Google Play. For more information about mobilePDR, visit PDR.net/mobilePDR.

    Media Contact:
    Lisa Damico

    # # #